113 related articles for article (PubMed ID: 12679396)
41. Clinical applications of (18)F-FDG in oncology.
Nabi HA; Zubeldia JM
J Nucl Med Technol; 2002 Mar; 30(1):3-9; quiz 10-1. PubMed ID: 11948260
[TBL] [Abstract][Full Text] [Related]
42. PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.
Endo K; Oriuchi N; Higuchi T; Iida Y; Hanaoka H; Miyakubo M; Ishikita T; Koyama K
Int J Clin Oncol; 2006 Aug; 11(4):286-96. PubMed ID: 16937302
[TBL] [Abstract][Full Text] [Related]
43. 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma.
Kostakoglu L; Goldsmith SJ
J Nucl Med; 2003 Feb; 44(2):224-39. PubMed ID: 12571214
[TBL] [Abstract][Full Text] [Related]
44. Clinical utility of FDG PET.
Otsuka H; Graham M; Kubo A; Nishitani H
J Med Invest; 2004 Feb; 51(1-2):14-9. PubMed ID: 15000251
[TBL] [Abstract][Full Text] [Related]
45. [Clinical usefulness of FDG-PET in oncology].
Sasaki M
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
[TBL] [Abstract][Full Text] [Related]
46. Whole-body FDG-PET imaging in the management of patients with cancer.
Hustinx R; Bénard F; Alavi A
Semin Nucl Med; 2002 Jan; 32(1):35-46. PubMed ID: 11839068
[TBL] [Abstract][Full Text] [Related]
47. Clinical role of positron emission tomography in oncology.
Bomanji JB; Costa DC; Ell PJ
Lancet Oncol; 2001 Mar; 2(3):157-64. PubMed ID: 11902566
[TBL] [Abstract][Full Text] [Related]
48. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) --usefulness and limitations in "clinical reality".
Higashi T; Saga T; Nakamoto Y; Ishimori T; Fujimoto K; Doi R; Imamura M; Konishi J
Ann Nucl Med; 2003 Jun; 17(4):261-79. PubMed ID: 12932109
[TBL] [Abstract][Full Text] [Related]
49. [Clinical application of FDG-PET for cancer diagnosis].
Nakamoto Y
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Jul; 63(6):285-93. PubMed ID: 12934545
[TBL] [Abstract][Full Text] [Related]
50. Quantitative assessment of tumor metabolism using FDG-PET imaging.
Weber WA; Schwaiger M; Avril N
Nucl Med Biol; 2000 Oct; 27(7):683-7. PubMed ID: 11091112
[TBL] [Abstract][Full Text] [Related]
51. PET in oncology: will it replace the other modalities?
Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
[TBL] [Abstract][Full Text] [Related]
52. [Positron-emission tomography in oncology].
Zaplatnikov K; Menzel C; Döbert N; Diehl M; Hamscho N; Grünwald F
Klin Med (Mosk); 2003; 81(12):13-21. PubMed ID: 14971150
[TBL] [Abstract][Full Text] [Related]
53. PET imaging in oncology.
Bar-Shalom R; Valdivia AY; Blaufox MD
Semin Nucl Med; 2000 Jul; 30(3):150-85. PubMed ID: 10928381
[TBL] [Abstract][Full Text] [Related]
54. Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma.
Stokkel MP; Draisma A; Pauwels EK
J Cancer Res Clin Oncol; 2001 May; 127(5):278-85. PubMed ID: 11355142
[TBL] [Abstract][Full Text] [Related]
55. Extranodal manifestations of lymphoma on [¹⁸F]FDG-PET/CT: a pictorial essay.
Kashyap R; Rai Mittal B; Manohar K; Balasubramanian Harisankar CN; Bhattacharya A; Singh B; Malhotra P; Varma S
Cancer Imaging; 2011 Nov; 11(1):166-74. PubMed ID: 22123338
[TBL] [Abstract][Full Text] [Related]
56. [18F FDG PET- applications in oncology].
Răileanu I; Rusu V; Stefănescu C; Cinotti L
Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):638-45. PubMed ID: 12092212
[TBL] [Abstract][Full Text] [Related]
57. Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: A systematic review.
Sprinz C; Altmayer S; Zanon M; Watte G; Irion K; Marchiori E; Hochhegger B
PLoS One; 2018; 13(2):e0193140. PubMed ID: 29486008
[TBL] [Abstract][Full Text] [Related]
58. A shifting landscape: what will be next FDG in PET oncology?
Inoue T; Oriuchi N; Tomiyoshi K; Endo K
Ann Nucl Med; 2002 Feb; 16(1):1-9. PubMed ID: 11922202
[TBL] [Abstract][Full Text] [Related]
59. [Cost-effective PET scans in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Várady E; Galuska L; Trón L; Esik O
Orv Hetil; 2002 May; 143(21 Suppl 3):1255-61. PubMed ID: 12077909
[TBL] [Abstract][Full Text] [Related]
60. Nuclear imaging of bone tumors: FDG-PET.
Aoki J; Inoue T; Tomiyoshi K; Shinozaki T; Watanabe H; Takagishi K; Endo K
Semin Musculoskelet Radiol; 2001 Jun; 5(2):183-7. PubMed ID: 11500164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]